Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Cushing syndrome presents with a wide array of symptoms, many of which result from prolonged exposure to elevated cortisol ...

Senator DiDomenico and his colleagues in the Legislature passed comprehensive reforms that will lower the cost of prescription drugs at the pharmacy counter and improve oversight of the state’s ...

For the thousands of people who have asthma (a chronic lung disease that impacts your airways), the thought of vigorous exercise may be daunting. They ...

Centre, a national research platform led by Nanyang Technological University, Singapore’s (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine), will lead a multi-institutional research ...

How can a long-standing cough that does not produce phlegm, and stops as soon as you fall asleep, be cured by watching a ...

Australia's Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people w ...

Although cost-related asthma treatment nonadherence has declined in the US, nearly 1 in 6 patients are still nonadherent due to cost concerns.

A new study by researchers from the Brown University School of Public Health found that pregnant women are regularly excluded ...

Montelukast (Singulair) held no elevated risk of depression, anxiety, suicidality, or behavioral problems for children, ...